With over 4.11 million FSD Pharma Inc. (HUGE) shares trading Monday and a closing price of $3.18 on the day, the dollar volume was approximately $13.06 million. The shares have shown a positive weekly performance of 10.03% and its price on 08/31/20 lost nearly -1.85%. Currently, there are 12.98M common shares owned by the public and among those 9.92M shares have been available to trade.

An analysis of what Wall Street brokers have to say about the expected price targets for this stock gives us this picture: 1 analysts who have offered their price forecasts for HUGE have a consensus price objective of $8.36. The analysts have set the share’s price value over the next 12 months at a high of $8.36 and a low of $8.36 should the stock experience a downside. But an upside of 61.96% will see the stock hit the forecast high price target while mean target price for the stock is $8.36.

Horizons Medical Marijuana Life S owns 24856.0 shares of the company’s stock, all valued at over $90227.0.

Shares of FSD Pharma Inc. (NASDAQ: HUGE) opened at $3.47, up $0.23 from a prior closing price of $3.24. However, the script later closed the day at $3.18, down -1.85%. The company’s stock has a 5-day price change of 10.03% and 2.58% over the past three months. HUGE shares are trading -41.42% year to date (YTD), with the 12-month market performance down to -78.94% lower. It has a 12-month low price of $2.39 and touched a high of $17.49 over the same period. Currently, 4.11 million shares have been traded, compared to an average intraday trading volume of 940.12K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 6.37%, -9.69%, and -26.55% respectively.

Institutional ownership of FSD Pharma Inc. (NASDAQ: HUGE) 12.98M shares outstanding. Mutual fund holders own –, while other institutional holders and individual stakeholders account for — and — respectively.

It has a market capitalization of $41.28M. Price movements for the stock have been influenced by the stock’s volatility, which stands at 11.64% over the week and 8.84% over the month.

Specifically, 1 Wall Street analysts polled rate the stock as a buy, while 0 of the 1 advise that investors “hold,” and 0 rated it as a “Sell.”